Clinical Trials Update: Jul 29, 2010
(HealthDay News) -- Here are the ultimate clinical trials, pleasantness
of ClinicalConnection.com:
Gout
This investigate is evaluating an investigational drug in
people with gout and heart disease. Participants will embrace
study-related exams, labs, and investigate drug at no cost.
The investigate
site is in Gilbert, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
-----
Fibromyalgia
This investigate is for people elderly 18 to 65 who have been
diagnosed with fibromyalgia. The hearing will weigh ways to safely
increase the earthy wake up of adults with the condition.
The
research site is in Baltimore, Md.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/fibromyalgia.aspx.
-----
Sort 2 Diabetes
This investigate will weigh the reserve and efficacy
of an investigational verbal sort 2 diabetes medication, when used alone or
in multiple with metformin.
The investigate site is in Salt Lake
City, Utah.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
-----
Copyright 2010 ClinicalConnection.com. All rights reserved.
More Health News
Write on
Health News | Jul 29, 2010 |
Tags:
Related posts about Clinical Trials Update Jul 29, 2010
The New England Journal Of Medicine Table Of Contents July 29
In this clinical trial of dispatcher-assisted bystander cardiopulmonary resuscitation CPR, results were similar with chest compressions alone and with chest compressions plus rescue breathing. However, patients with a cardiac On April 29, 2010, the Food and Drug Administration FDA approved a new immunotherapy, sipuleucel-T, for the treatment of patients with asymptomatic or minimally symptomatic castration-resistant prostate cancer. Traditionally, immune-based -
nejm.org
Sleep Apnea Clinical Trial Sleepiness And The Effects Of CPAP On
Date First Received September 3, 2010. Last Updated September 7, 2010. Verified by Medical College of Wisconsin, September 2010. Clinical Trial Phase NA Start Date November 2004. Overall Status Active, not recruiting . 2004 Jun 295636-50. Chatterton RT Jr, Vogelsong KM, Lu YC, Ellman AB, Hudgens GA. Salivary alpha-amylase as a measure of endogenous adrenergic activity. Clin Physiol. 1996 Jul164433-48. Skosnik PD, Chatterton RT Jr, Swisher T, -
clinicaltrialsfeeds.org
The Lord Is My Shepherd Update- July 29, 2010
Update- July 29, 2010. DEAR FRIENDS AND LOVED ONES I JUST RECEIVED MY LATEST UPDATE FROM MY ONCOLOGIST'S OFFICE AND I WILL BEGIN MY CLL CHEMO-THERAPY TREATMENT ON TUESDAY AUGUST 3RD. THE GOAL IS TO TRY TO GET CHEMO DONE BY CHRISTMAS TIME IF POSSIBLE. Comparative multicenter trials of PCR versus FCR or other F-based regimens will be of interest, as will correlative studies of responses among clinical, phenotypic, and molecular subsets of CLL patients. -
thelordismyshepherd3.blogspot.com
PennyToBuck.com Stock Update On OREX, ULTA And CRWE For - Thursday
Its lead combination product candidates include Contrave, which has completed Phase III clinical trials and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained Ulta Salon, Cosmetics Fragrance, Inc. NASDAQULTA, recently announced on September 2nd, 2010 financial results for the thirteen week period Second Quarter and twenty-six week period First Six Months ended July 31, 2010 , -
stockreads.com
Crossover 9.1 Rapidshare Free Full s With Hotfile And
This monograph presents a comprehensive and up-to-date account of the developments in optimality aspects of crossover designs. Crossover designs are immensely useful in various areas of human investigation including agriculture, animal nutrition, clinical trials, pharmaceutical studies, biological assays, weather modification experiments, sensory evaluation of food products and learning experiments. 29 July 2010 Read More -
worldsdown.net